| abstract |
An preparation for treating systemic lupus erythematosus containing the following compound: <CHEM> wherein, when n is 1, Z represents a hydrogen, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium, as an active ingredient and pharamacologically permittable carrier. The preparation of the present invention may be used in any administration method such as hypodermic, intramuscular and intravenous. |